Antifungal Drugs Market Size, Share & Trends Report

Antifungal Drugs Market Size, Share & Trends Analysis Report By Drug Class (Azoles, Polyenes), By Indication (Dermatophytosis, Aspergillosis), By Dosage Form, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-1-68038-293-8
  • Number of Pages: 100
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Antifungal Drugs, Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
    • Azoles
    • Echinocandins
    • Polyenes
    • Allylamines
    • Others
  • Antifungal Drugs Indication Outlook (Revenue, USD Million, 2018 - 2030)
    • Dermatophytosis
    • Aspergillosis
    • Candidiasis
    • Others
  • Antifungal Drugs Dosage Form Outlook (Revenue, USD Million, 2018 - 2030)
    • Oral Drugs
    • Ointments
    • Powders
    • Others
  • Antifungal Drugs Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospital Pharmacies
    • Retails Pharmacies
    • Others
  • Antifungal Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Antifungal Drugs Market, by Drug Class
        • Azoles
        • Echinocandins
        • Polyenes
        • Allylamines
        • Others
      • North America Antifungal Drugs Market, by Indication
        • Dermatophytosis
        • Aspergillosis
        • Candidiasis
        • Others
      • North America Antifungal Drugs Market, by Dosage Form
        • Oral Drugs
        • Ointments
        • Powders
        • Others
      • North America Antifungal Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retails Pharmacies
        • Others
      • U.S.
        • U.S. Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • U.S. Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • U.S. Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • U.S. Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Canada
        • Canada Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Canada Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Canada Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Canada Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
    • Europe
      • Europe Antifungal Drugs Market, by Drug Class
        • Azoles
        • Echinocandins
        • Polyenes
        • Allylamines
        • Others
      • Europe Antifungal Drugs Market, by Indication
        • Dermatophytosis
        • Aspergillosis
        • Candidiasis
        • Others
      • Europe Antifungal Drugs Market, by Dosage Form
        • Oral Drugs
        • Ointments
        • Powders
        • Others
      • Europe Antifungal Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retails Pharmacies
        • Others
      • Germany
        • Germany Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Germany Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Germany Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Germany Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • UK
        • UK Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • UK Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • UK Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • UK Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • France
        • France Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • France Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • France Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • France Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Italy
        • Italy Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Italy Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Italy Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Italy Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Spain
        • Spain Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Spain Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Spain Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Spain Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Denmark
        • Denmark Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Denmark Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Denmark Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Denmark Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Sweden
        • Sweden Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Sweden Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Sweden Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Sweden Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Norway
        • Norway Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Norway Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Norway Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Norway Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
    • Asia Pacific
      • Asia Pacific Antifungal Drugs Market, by Drug Class
        • Azoles
        • Echinocandins
        • Polyenes
        • Allylamines
        • Others
      • Asia Pacific Antifungal Drugs Market, by Indication
        • Dermatophytosis
        • Aspergillosis
        • Candidiasis
        • Others
      • Asia Pacific Antifungal Drugs Market, by Dosage Form
        • Oral Drugs
        • Ointments
        • Powders
        • Others
      • Asia Pacific Antifungal Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retails Pharmacies
        • Others
      • China
        • China Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • China Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • China Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • China Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Japan
        • Japan Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Japan Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Japan Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Japan Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • India
        • India Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • India Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • India Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • India Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Thailand
        • Thailand Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Thailand Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Thailand Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Thailand Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • South Korea
        • South Korea Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • South Korea Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • South Korea Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • South Korea Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Australia
        • Australia Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Australia Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Australia Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Australia Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
    • Latin America
      • Latin America Antifungal Drugs Market, by Drug Class
        • Azoles
        • Echinocandins
        • Polyenes
        • Allylamines
        • Others
      • Latin America Antifungal Drugs Market, by Indication
        • Dermatophytosis
        • Aspergillosis
        • Candidiasis
        • Others
      • Latin America Antifungal Drugs Market, by Dosage Form
        • Oral Drugs
        • Ointments
        • Powders
        • Others
      • Latin America Antifungal Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retails Pharmacies
        • Others
      • Brazil
        • Brazil Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Brazil Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Brazil Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
      • Mexico
        • Mexico Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Mexico Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Mexico Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Mexico Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Argentina
        • Argentina Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Argentina Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Argentina Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Argentina Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
    • Middle East and Africa
      • Middle East and Africa Antifungal Drugs Market, by Drug Class
        • Azoles
        • Echinocandins
        • Polyenes
        • Allylamines
        • Others
      • Middle East and Africa Antifungal Drugs Market, by Indication
        • Dermatophytosis
        • Aspergillosis
        • Candidiasis
        • Others
      • Middle East and Africa Antifungal Drugs Market, by Dosage Form
        • Oral Drugs
        • Ointments
        • Powders
        • Others
      • Middle East and Africa Antifungal Drugs Market, by Distribution Channel
        • Hospital Pharmacies
        • Retails Pharmacies
        • Others
      • South Africa
        • South Africa Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • South Africa Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • South Africa Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • South Africa Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Saudi Arabia
        • Saudi Arabia Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Saudi Arabia Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Saudi Arabia Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Saudi Arabia Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • UAE
        • UAE Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • UAE Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • UAE Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • UAE Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others
      • Kuwait
        • Kuwait Antifungal Drugs Market, by Drug Class
          • Azoles
          • Echinocandins
          • Polyenes
          • Allylamines
          • Others
        • Kuwait Antifungal Drugs Market, by Indication
          • Dermatophytosis
          • Aspergillosis
          • Candidiasis
          • Others
        • Kuwait Antifungal Drugs Market, by Dosage Form
          • Oral Drugs
          • Ointments
          • Powders
          • Others
        • Kuwait Antifungal Drugs Market, by Distribution Channel
          • Hospital Pharmacies
          • Retails Pharmacies
          • Others

Antifungal Drugs Market Dynamics

Driver: Growing incidences of fungal infections among the population

The rising incidence rate of infections of a fungal origin is a leading factor contributing to the overall market growth. These infections include both superficial and systemic infections, including infections of the eye, mouth, vagina, and skin. Antifungal products with fungicidal activity are utilized in treating conditions such as fungal meningitis, athlete's foot, and ringworm, which are caused by fungal agents. Each year, over 300 million people suffer from a serious fungal infection and over 25 million are at risk of death or losing their eyesight. Over 150,000 patients admitted to ICUs develop Candida in Europe, the U.S., and Japan. As per the CDC, in 2021, around 7,199 deaths occurred due to fungal infections in the United States. Moreover, there is a severe threat of fungal infections to people with weak immune responses such as AIDS-afflicted patients. According to statistics by the CDC, every year, nearly 152,000 new individuals are affected by cryptococcal meningitis, which is a brain infection and results in 112,000 deaths annually globally. Most of the deaths are reported in sub-Saharan Africa, as the prevalence of HIV/AIDS is more in these countries. This indicates a potential unmet need for highly potent antifungal drugs. 

Driver: Growing R&D regarding novel drug development in this space

The need for antifungal drugs is globally accepted owing to the high mortality rate of fungal infections. The R&D is widely led by small research-based pharmaceutical and biotechnology companies and bigger players are focused on more lucrative products. Furthermore, major players are using acquisition strategies to enhance their pipeline for antifungals. There are over 130 clinical studies in progress for antifungal drugs for various conditions such as otomycosis, vulvovaginal candidiasis, and invasive aspergillosis. In August 2020, F2G Ltd. received funding of USD 60.8 million for its antifungal drug F901318 (olorofim), which at that point was in the late stage of development. In July 2020, positive results for phase II clinical trials were announced by Amplyx Pharmaceuticals for its novel drug candidate fosmanogepix, used for the treatment of fungal infections caused by Candida, Aspergillus, and rare molds. In April 2022, the FDA approved Mycovia Pharmaceuticals’ Vivjoa (oteseconazole capsules) for the treatment of recurrent vulvovaginal candidiasis, which had demonstrated support from the regulatory agency for new research molecules. Such developments in novel drugs and increased funding for R&D are projected to act as growth drivers.  

Restraint: Rising resistance to antifungal drugs

Increasing resistance to antifungal drugs is becoming an issue globally. This puts transplant and intensive care patients at the highest risk, as their immune system is compromised. As per a report by Imperial College London in 2018, hospitalized patients, HIV patients, and the elderly are also at a high risk of these diseases. Multidrug resistance in fungal strains such as Candida auris has increased the severity of invasive infections. Azole-resistant aspergillus strains such as A. fumigatus lead to an escalated number of respiratory infections in patients with weak respiratory systems. Moreover, patients suffering from invasive fungal infections such as infections in the heart, blood, eyes, and brain are of major concern due to drug resistance. This has created an urgent need for novel highly potent antifungal drugs as fungal infections have one of the highest mortality rates.

What Does This Report Include?

This section will provide insights into the contents included in this antifungal drugs market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Antifungal drugs market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Antifungal drugs market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon